Legend Capital
Legend Capital is a leading VC&PE investor focusing on early-stage and growth-stage opportunities in China. It manages over US$10 billion in commitments and has invested in around 600 companies across various sectors. The firm emphasizes long-term sustainable investment and incorporates ESG factors into its strategy.
📥 Buy Full VC Dataset
Offices: Beijing (China), Shanghai (China), Shenzhen (China), Hong Kong (China), Seoul (South Korea), Singapore (Singapore)
Investment Stages: Seed, Series A, Series B, Series C
Markets: Technology, Healthcare, Consumer, Enterprise service, Intelligent manufacturing
Founded Year: 2001
Investor Type: Venture Capital, Private Equity
Portfolio Companies: CATL, Putailai, Wuxi Lead Intelligent Equipment Co., Ltd, CNGR Advanced Material Co., Ltd, YUTO Tech, Shaanxi Light Optoelectronic Materials Co., LTD, Hymson, Shenzhen Colibri Technologies Co., Ltd, Cybrid Technologies, Shenzhen Yanmade Technology Inc., Guangdong Kaijin New Energy Technology Co., Ltd, iFLYTEK, Spreadtrum communication, Apex Microelectronics, Fullhan Microelectronics, UCloud, Kunlun chip, Horizon Robotics, Huice, Haizhi BDP, Pony.AI, Beijing ESWIN Technology Group Co. Ltd, ZongmuTech, Atour, Bilibili, GAMBOL PET GROUP, Tuhu, Youdao, Wish, Dookbook, Bloks Group, DiDi Bike, Taihe Music Group, JD Logistics, China Eastern Airlines Logistics, Milkyway Chemical Supply Chain Service Co., LTD, HICHAIN logistics, Renrui, KNX, China Southern Air Logistics, Shuhai supply chain, SF Express, SF cityrush, JWM, Pharmaron, WuXi AppTec, WuXi Biologics, Innovent, KingMed, Yixintang, Baheal Medical Inc., New Horizon Health, Berry Genomics, Chemclin Diagnostics, Wuhan EasyDiagnosis Biomedicine Co., Ltd, Harbour BioMed, Beijing Kawin Technology, Recbio Technology, Deepwise
Website: https://www.legendcapital.com.cn/index_en.aspx?id=0
LinkedIn: https://www.linkedin.com/company/legend-capital/
Crunchbase: https://www.crunchbase.com/organization/legend-capital
Comments
No comments yet. Be the first to comment!